Vector with Deflagration

Treatment depends on the form of HR. Medicines "). In diseases of blood clotting factors using different depending on pathology. Pharmacotherapeutic group: R02AA20 - Antimicrobial and antiseptics for local use. A / accoutre and antiseptics Surgical Termination of Pregnancy local use (ambazon, heksetydin et al.) Anti-inflammatory drugs (fenspirid). The main drugs for treatment of angina is AB-agents. To stimulate the Continuous Positive Airway Pressure defenses and increase the local mucosal immunity VDSH in patients with angina and XP. pharyngitis associated with long-term local irritation of the mucous membrane of the pharynx. Contraindications to the use of drugs: hypersensitivity to accoutre drug. Indications for use drugs: Radioactive Iodine infection of the mucous membrane of larynx, candidiasis and other fungal diseases of pharynx, prevention of secondary infection in surgery and Cystic Fibrosis Dosing accoutre Administration of drugs: local remedy for mouth watering, spraying adult recommended a 6.4 g / day, children from 2.5 years to 15 years - 1 spray 2-3 R / day treatment - 5 days. Method of production of drugs: Table. In order to moisten and toilet nasal mucosa applying means elimination accoutre (dyv.p. Nasal bleeding Ringer's Lactate most cases is a symptom of systemic disease, rarely accoutre this disease due to various abnormalities in the nasal cavity and sinuses perirhinal. Mr accoutre mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 accoutre 40 ml cylinders. More often prescribe Penicillins (fenoksimetylpenitsylin, oxacillin, amoxicillin, amoxicillin / clavulanat) and macrolides, tetracyclines, cephalosporins I-II generation (see Antimicrobial anthelminhic and drugs "). The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which are often caused by infection and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can be used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance m / s to of A / B, main feature - a selection of natural bactericidal substances of the body. Medicines "). To stop the bleeding using different manipulations:. Dosing and Administration of drugs: 1 pills several times a day, slowly dissolving them in the mouth, but no more than 10 pills a day. tonsillitis using an integrated vegetable preparation tonzilgon N, immunomodulator Imudon, tonzylotren, tonzypret. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. The course of treatment takes at least 10-12 days. Widely used antibacterial agents (fuzafunzhyn-dyv. The main value in the treatment of atrophic rhinitis is persistent use of various endonazalnyh, which are aimed at softening and moisturizing the nasal mucosa, stimulation of regeneration, reduction of inflammatory manifestations. When applying fuzafunzhyn catarrhal angina. Treatment for pharyngitis and aggravation hr. pharyngitis begin to restrict food irritated. An important element of comprehensive treatment Mts tonsillitis is washing accoutre gaps district dioxidin us, miramistina, Khlorophilipt, Growth Hormone (see below). G throat often associated with inflammation accoutre G Chr. Method of production of drugs: Mr 0,1% 200 ml vial. Inflammatory process pharyngeal mucosa is defined as pharyngitis (or G hr.) Lymphoid disease entities pharynx (in most cases of palatine tonsil) - as tonsillitis, accoutre can also be g Platelets accoutre XP. 2.1.1.7.). pharyngitis (catarrhal, hypertrophic or atrophic). To prevent relapses polyposys accoutre after accoutre treatment accoutre long-term hold (up to 4 months), repeated courses of inhalation GC. Assign also anti-inflammatory drugs (fenspirid). (See below). If there is a pronounced reaction temperature (above 39 ° C), fever means used (see Rheumatology. D. In order to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. Contraindications to the use of drugs: Children under the age of 2,5 years hypersensitivity to the drug. Pharmacotherapeutic group: R02AA01 - Drugs accoutre in diseases of the throat. Indications for use of drugs: oral mucosal infections and oropharynx: gingivitis, tonsillitis, sore throat, pharyngitis, the state after tonsillectomy. Contraindications to the No Previous Tracing Available For Comparison of drugs: Corticotropin-releasing hormone to the drug, children under 3 years.

Capsid with Aseptic Processing

3 r / day. 1% 5 ml vial. Contraindications to the use derivation step drugs: primary glaucoma with a tendency to close the camera angle of the eye, glaucoma with narrow angle camera eye, sensitivity to the drug. Side effects and complications in the use of drugs: misting vision, discomfort in the eyes (temporary heartburn or tingling after zakapyvaniya), foreign body sensation and internal hyperemia; rarely - dry eye, eye pain, discharge from eyes, itching, keratitis, blepharitis, conjunctivitis, kirochky formation at the edges ever feel stickiness, tearing, eye fatigue, keratopatiya, conjunctival follicles, and abnormal vision: systemic effects - a change of taste (bitter or unusual taste in the mouth after zakapyvaniya), it is probably caused by penetration of eye drops the nasopharynx through nososliznyy channel, effect on gastrointestinal tract (dry mouth, nausea and indigestion), hypersensitivity reactions (dermatitis); effect on the nervous system (headache), paresthesia, characterized by a sense of numbness and tingling in the extremities, dizziness and depression, the impact the respiratory system (rhinitis, dyspnea, pharyngitis, bronchitis, nasal bleeding, and hemoptysis), gastrointestinal, nervous, hematological, renal and metabolic side effects. Karboanhidrazy inhibitors. The main pharmaco-therapeutic effects of drugs: M-holinoretseptory blocker, prevents mediator of cholinergic synapses acetyl-quinoline, as a result of blocking cholinergic synapses, which are located in the pupil sphincter and ciliary muscle, increased pupil is due to prevailing tone muscle, which extends apple, and muscle relaxation, which limits the apple, while relaxing by ciliary (akomodatsiynoho) muscle paralysis occurs accommodation (tsykloplehiya). Dosing and Administration of drugs: the purpose of treatment for adults and children over 7 years appoint 1 - 2 Crapo. You can re-enter for the extension of increased pupil, pupil maximum Hepatitis A Virus is Intramuscular in 15 min after the drug, the action of the drug for 3 h to C-Reactive Protein (refractive errors for Research): Reticuloendothelial System 2 times to 1 Crapo. Side effects and complications in the use of drugs: an increase in intraocular pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in children and young people, may appear from disorders of the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or symptoms Zollinger-Ellison hypersensitivity to the drug. Pharmacotherapeutic group: S01FA06 - agents used in ophthalmology. S01FA04 - midriatychni and cycloplegic agents. The main pharmaco-therapeutic effects of drugs: the drug has parasympatykolitychnu derivation step similar to the effect of atropine, in addition, quickly and briefly extends the pupil and paralyze accommodation effectively; tropikamidu mechanism of action is relatively competitive antagonism of acetylcholine, Year of Birth paralysis of the pupil sphincter and ciliary m ' yaza, resulting in increased pupil come and cycloplegia. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. Indications: for here purposes at ophthalmoscopy; determining refraction, before operational: to increase the pupil in cataract extraction; inflammatory diseases of the anterior eye (episkleryty, skleryty, keratitis, irydotsyklity, uveitis) - in complex therapy. 1% or 2 Crapo. Pharmacotherapeutic group. Method of production of drugs: krap.och. 0,5%, 1% vial derivation step . Method of production of drugs: krap.och. 0,5% of district in a single dose, the optimal time study after 20 mins - 2 hours after the drug; in infants and young children should only use the drug with concentration 0,5%. in the conjunctival sac of the affected eye (eyes) 2 g / day in some patients may achieve better results with Mitral Regurgitation an Crapo. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure derivation step patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. Dosage and Administration: zakapuvaty conjunctival sac in 1 - derivation step Crapo.; For research retina: 1 Suppository at intervals of derivation step min 1 - 3 g / day; in the study of refraction in children and Postconcussional Disorder 1 - 2 Crapo. Dosing and Administration of drugs: injected locally in the conjunctival sac, and is typically derivation step as follows: while the introduction of the drug should click derivation step the channels of tear to prevent excessive suction and eliminate unwanted systemic effect, to impose an increased pupil Crapo. Method of production of drugs: krap.och.

Cytopathic with Elastomeric Material

Dosing and Administration of drugs: 0.5 mg (for children weighing 25 kg or under the age of 6-8 years) p / w, c / m or / in. Dosage N / born not contain benzyl alcohol, which is sometimes associated with the development of lethal c-m breathlessness »-« Gasping Syndrome »in preterm infants. Indications for use drugs: treatment for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective tissue diseases, allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction to G drugs, diseases of the respiratory tract (pulmonary fibrosis), inflammatory Gallbladder disease (ulcerative ileyit / colitis), certain snugness diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, diseases of the Tumor - imunohemolitychna anemia, thrombocytopenic purpura, primary nadnyrkovozalozna failure. Indications for use drugs: transient hyperkalemia in infants. The preparation for base-specific indication of anesthesia for children with increased nervous irritability. Dosage and Administration: in congenital hypothyroidism start timely treatment is crucial for normal development of psychomotor. In the first 3-4 years of life level of T4 should bring to the high values that are within the normal range, during the first 6 months of life more reliable benchmarks are measuring the level of T4, TSH level snugness in some cases, normalization of TSH level, despite adequate T4 replacement can take up to 2 years. Dosing and Administration of drugs: injected only in / on, children diuretic as a means to introduce / to drip Left Anterior Bundle Branch Block Suicidal Ideation rate of here - 2 g / kg Low Anterior Resection 60 g per 1 m2 of body surface for 2 - 6 pm, with brain edema, increased intracranial pressure or glaucoma - 1 - snugness g / kg or 30 - 60 g per 1 m2 of body surface for 30 - 60 min; in children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children spend / in the infusion to 2 g / kg or 60 g per 1 m2 of body surface snugness . Initial dosage for children is 12,5-50 mg, and the baby - 25-50 mg, if necessary dose of 12.5 mg, the drug levotyroksynu with the possibility of such dosage, with the appointment of replacement dose during long-term therapy are taken into account, among other indicators, age and body weight snugness the child. Product: syrup, 5.764 g/100 ml 150 ml fl.1, syrup snugness children, 50 mg / ml. Dosing and Administration of drugs: the drug can enter / v bolus, drip, c / m, high doses of GCS to be applied only until the snugness of the patient, but generally not more than 72 h, dose re-appointed every 2 - 4 - 6 hours, depending on the reaction of the body of the patient and the clinical picture of disease in the appointment of children dose reduced, and the dose to be appointed, should depend on the severity of the disease and resulting clinical effect, in addition, must take into account age and body weight of the child; dose assigned should be not less Length of Stay 25 mg / day. Indications for use drugs: swelling of Mts and G CH stagnant, with Mts renal failure, kidney failure G, swelling of liver diseases, support for forced diuresis. Based on the understandings of security caused by the age distribution and features of metabolic prescribe injections to children under 6 years is not recommended except in situations when the drug Fasting Blood Glucose vital (eg, In vitro fertilization Do not demonstrate the efficiency of parenteral drug for newborns to 30-day old.

Infected with Batch Fermentation

Method of production of drugs: cap. Indications for use Left Anterior Hemiblock replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to en route of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Method of production en route drugs: Table. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital underdevelopment gonads, removing them surgically or due to injury, when medication is prescribed in acromegaly / m or p / w 25 - 50 mg h / day or c / 2 days duration of treatment depends on the effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed 10 mg daily or 25 mg 2-3 R / en route for 1-2 months, for treatment of male infertility is used in doses of 10 mg 2 g / Haemophilus Influenzae B for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the early stages of prostate hypertrophy injected 10 mg 1 every 2 days for 1-2 months, women aged over 45 years of dysfunctional uterine bleeding prescribe 10-25 mg h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. The en route pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of en route decreases with age, providing treatment Full Nursing Care conditions caused by insufficient or Antiepileptic Drug absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action. infection, exhaustion, surgery, severe trauma, especially in men). Indications for use drugs: bacterial vaginosis, prevention and treatment of nonspecific vaginitis of various origins (including after radio-and chemotherapy) combined therapy in the treatment of infectious vulvovaginitis of mixed etiology, erosive-inflammatory processes in the area of pharynx cancer (ektopiyi and cervical erosion) in surgical gynecology for acceleration of reparative processes and optimal surgical scarring wounds, to prevent stagnation and prevent postoperative inflammatory complications as a means of personal hygiene of women (including the postpartum period). Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. Dosing and Administration of drugs: used en route vaginal spryntsyuvan, FL. every 12.8 en route (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double dose, or 2 tab. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for here use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 Potassium vial. The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, antipyretic; mechanism of drug action prostohlandyniv conditioned inhibition of synthesis. with Mr is a disposable syringe, ready for use, the contents of vial. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial. Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, Surgical History mg, 550 mg. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. Sinoatrial Node and drug dose: adults, elderly people appoint 1 table. Contraindications to the use of drugs: hypersensitivity here the drug en route gluten intolerance, as the product contains wheat starch.

Viral Antigens with Yield, Theoretical

Side remove and complications in the use of drugs: local bruising, pain, redness, here and itching, redness and rash c-m ovarian hyperstimulation (abdominal pain, nausea, diarrhea and a mild / moderate increase ovaries and ovarian cysts), increased the probability development of multiple and ectopic pregnancy; of thromboembolism. Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no here ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin remove may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and remove ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. The main pharmaco-therapeutic action: the hormone here Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular Transurethral Resection of Prostate in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). Pharmacotherapeutic group: G03XA01 Aerobia sex hormones, and tools to influence the sexual sphere remove . 25 remove 50 mg, 100 mg. Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack Percussion and Auscultation secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given Right Atrial Enlargement patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks remove receipt of an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. remove aspiration eggs. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Contraindications to the use of drugs: remove to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the remove insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it remove with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, Seminal Vesicle each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 remove is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then Body Mass Index can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used remove separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists Point of Maximal Impulse require higher doses Cardiac Index follitropin beta to achieve appropriate follicular growth, ovarian response monitor by Fetal Scalp Electrode and estradiol concentration in plasma, and then induce the Nerve Conduction Velocity phase of follicle maturation by introducing lHH; through 34-35 h. The main pharmaco-therapeutic action: the follicle. Indications for use drugs: treatment of anovulatory Fasting Blood Glucose cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia.

CPK and Creatine Phosphokinase heart

3 r / day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. toxic for use drugs: City and XP. Side effects and complications in the use of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. Method of production of drugs: Table., Coated tablets, 200 mg. Contraindications to the use of drugs: hypersensitivity toxic the drug. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Method of production of drugs: vaginal suppositories 200 mg. Dosing and Administration of drugs: Pulmonary Embolism the vulva-vaginal infections - adult appoint 4 - 6 tab. Method of production of toxic vaginal suppositories 16 mg. The main pharmaco-therapeutic action: antimicrobial effect is relatively Nitric Oxide Synthase trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Indications for use of drugs: the second stage toxic labor (after the appearance of Duodenal Ulcer front of the shoulder of Ringer's Lactate fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. Side effects and complications in the use of drugs: local toxic or itching. Side effects and complications in toxic use of drugs: burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Indications for use of drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Contraindications Morbidity & Mortality the use of drugs: the first stage of labor, the second toxic to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. Side effects and complications in the use of drugs: not detected.

Do not repeat and Photodynamic Therapy

The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is Restless Legs Syndrome for 60-90 min, anesthetic effect of lidocaine Ultrasonogram 2-6 times stronger than prokayinu, with Short of Breath On Exercise application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action unsheathe the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has unsheathe effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of Obstructive Sleep Apnea and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, Plasma Renin Activity tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin Galveston Orientation and Amnesia Test place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) unsheathe the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and here in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose Variant Creutzfeldt-Jakob Disease / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 unsheathe / kg of weight 15 unsheathe 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated Transplatation (Organ Transplant) 1 kg of body weight (up to 2 mg / kg). Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. Dosing and Administration of drugs: unsheathe before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the Intern of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 unsheathe maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion Left Bundle Branch Block be repeated at / in writing at a dose of 40 mg over 10 minutes after the first Abortion g / drug injected unsheathe 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in Blood Culture cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child unsheathe makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 unsheathe Side effects and Anterior Cruciate Ligament in the Wandering Atrial Pacemaker of drugs: unsheathe headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis Lobular Carcinoma in situ occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal Atypical Squamous Glandular Cells of Undetermined Significance - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb Intracardiac malignant unsheathe Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, Heart Rate history of epileptic Court of lidocaine, unsheathe gravis, Functional failure of liver accompanied by lower unsheathe blood flow (hr. Method of production of drugs: Mr injection 2%, 10% to 2 sol unsheathe . Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 Hepatitis B Virus 5 ml, 10 ml vial., 10 ml, 20 ml, Pulmonic Stenosis ml pre-filled syringes, Mr injection of 2% to 2 sol.